Table 4. World Health Organization–defined high-burden, low- and middle-income countries using or waiting for drug arrival to begin using bedaquiline under program conditions for treatment of multidrug-resistant tuberculosis.
| Currently using | Awaiting drug arrival |
|---|---|
| Armenia | Bangladesh |
| Belarus | Bolivia |
| Georgia | Brazil |
| Indonesia | Cameroon |
| Lesotho | Cote d’Ivoire |
| Papua New Guinea | North Korea |
| Russia | Democratic Republic of the Congo |
| South Africa | Ethiopia |
| Swaziland | India |
| Kazakhstan | |
| Kenya | |
| Kyrgyzstan | |
| Mozambique | |
| Myanmar | |
| Namibia | |
| Nigeria | |
| Peru | |
| Philippines | |
| South Korea | |
| Thailand | |
| Turkmenistan | |
| United Republic of Tanzania | |
| Uzbekistan | |
| Vietnam |